Irati Hervas-Corpion
Overview
Explore the profile of Irati Hervas-Corpion including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nava D, Ausejo-Mauleon I, Laspidea V, Gonzalez-Huarriz M, Lacalle A, Casares N, et al.
Neuro Oncol
. 2024 Mar;
26(8):1509-1525.
PMID: 38554031
Background: Pediatric high-grade gliomas (pHGGs), including diffuse midline gliomas (DMGs), are aggressive pediatric tumors with one of the poorest prognoses. Delta-24-RGD and ONC201 have shown promising efficacy as single agents...
2.
Cano-Cano F, Martin-Loro F, Gallardo-Orihuela A, Gonzalez-Montelongo M, Ortuno-Miquel S, Hervas-Corpion I, et al.
Sci Rep
. 2024 Feb;
14(1):4176.
PMID: 38378796
Huntington's disease (HD) is caused by an aberrant expansion of CAG repeats in the HTT gene that mainly affects basal ganglia. Although striatal dysfunction has been widely studied in HD...
3.
Ausejo-Mauleon I, Labiano S, Nava D, Laspidea V, Zalacain M, Marrodan L, et al.
Cancer Cell
. 2023 Oct;
41(11):1911-1926.e8.
PMID: 37802053
Diffuse intrinsic pontine glioma (DIPG) is an aggressive brain stem tumor and the leading cause of pediatric cancer-related death. To date, these tumors remain incurable, underscoring the need for efficacious...
4.
Hervas-Corpion I, Alonso M
Int Rev Cell Mol Biol
. 2023 Aug;
379:169-188.
PMID: 37541723
High-grade gliomas (HGGs) are the most common and aggressive primary brain tumors in both adult and pediatric populations. Despite the multimodal treatment modality currently available for HGG, the prognosis is...
5.
Hervas-Corpion I, Navarro-Calvo J, Martin-Climent P, Iriarte-Gahete M, Geribaldi-Doldan N, Castro C, et al.
Cells
. 2023 Feb;
12(3).
PMID: 36766715
Glioblastoma (GB) is the most prevalent primary brain cancer and the most aggressive form of glioma because of its poor prognosis and high recurrence. To confirm the importance of epigenetics...
6.
Hervas-Corpion I, Gallardo-Orihuela A, Catalina-Fernandez I, Iglesias-Lozano I, Soto-Torres O, Geribaldi-Doldan N, et al.
Cancers (Basel)
. 2021 Nov;
13(21).
PMID: 34771425
Glioblastoma (GB) is the most aggressive form of glioma and is characterized by poor prognosis and high recurrence despite intensive clinical interventions. To retrieve the key factors underlying the high...
7.
Valor L, Morales J, Hervas-Corpion I, Marin R
Int J Mol Sci
. 2021 Aug;
22(16).
PMID: 34445074
Abnormal trinucleotide expansions cause rare disorders that compromise quality of life and, in some cases, lifespan. In particular, the expansions of the CGG-repeats stretch at the 5'-UTR of the Fragile...
8.
Geribaldi-Doldan N, Hervas-Corpion I, Gomez-Oliva R, Dominguez-Garcia S, Ruiz F, Iglesias-Lozano I, et al.
Biomedicines
. 2021 Apr;
9(4).
PMID: 33916593
Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor and is associated with a poor prognosis. Despite the use of combined treatment approaches, recurrence is almost inevitable and...
9.
Valor L, Hervas-Corpion I
Front Oncol
. 2020 Dec;
10:602378.
PMID: 33344253
Glioma stem cells (GSCs) are crucial in the formation, perpetuation and recurrence of glioblastomas (GBs) due to their self-renewal and proliferation properties. Although GSCs share cellular and molecular characteristics with...
10.
Gallardo-Orihuela A, Hervas-Corpion I, Hierro-Bujalance C, Sanchez-Sotano D, Jimenez-Gomez G, Mora-Lopez F, et al.
Sci Rep
. 2019 Dec;
9(1):18696.
PMID: 31822756
Huntington disease (HD) is a fatal neurodegenerative disorder without a cure that is caused by an aberrant expansion of CAG repeats in exon 1 of the huntingtin (HTT) gene. Although...